People: Alnylam Pharmaceuticals Inc (ALNY.O)

ALNY.O on Nasdaq

2 Oct 2015
Change (% chg)

$3.37 (+4.23%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Search Stocks

Maraganore, John 

Dr. John M. Maraganore, Ph.D., is Chief Executive Officer, Director of Alnylam Pharmaceuticals, Inc. Dr. Maraganore also served as our President from December 2002 to December 2007. From April 2000 to December 2002, Dr. Maraganore served as Senior Vice President, Strategic Product Development for Millennium Pharmaceuticals, Inc. (now a wholly-owned subsidiary of Takeda Pharmaceutical Company Limited), a biopharmaceutical company. He also serves as a director of Agios Pharmaceuticals, Inc., bluebird bio, Inc. and the Biotechnology Industry Organization, a non-profit biotechnology trade organization, and formerly served as a director of Regulus Therapeutics Inc. from 2007 to May 2014.

Basic Compensation

Total Annual Compensation, USD 1,133,580
Restricted Stock Awards, USD --
Long-Term Incentive Plans, USD --
All Other, USD 7,596
Fiscal Year Total, USD 1,141,180

Options Compensation

  Quantity Market Value
Exercisable 764,108 7,795,030.00
Unexercisable 357,206 2,292,970.00
Exercised 18,617 332,593.00
Name Fiscal Year Total

John Clarke


Barry Greene


John Maraganore


Akshay Vaishnaw


Laurie Keating


David-Alexandre Gros

As Of  30 Dec 2014
Search Stocks